I just got a press release from Major League Baseball announcing that Phiten is now “The Official Compression Sleeve of Major League Baseball.”
You have heard of Phiten, of course. They make those ugly necklaces that provide no scientifically or medically proven benefits whatsoever, despite the fact that Phiten touts them for their ability to “promote stable energy flow throughout the body” and to provide “longer lasting energy, less fatigue, shortened recovery time and more relaxed muscles.” Indeed, Major League Baseball — whose players are given free Phiten necklaces for obvious promotional purposes — refers to them in the press release as “the innovator and original maker of precious metal-infused wellness products.”
The compression sleeve is something else. You’ve seen it: a spandexy-looking sleeve worn usually on one arm. They too are infused with Phiten’s “Aqua-Titanium technology,” and are supposed to “keep arm muscles warm and loose as well as to absorb moisture.” Which sort of sounds like a sleeve to me. Or a sweat band. Except those things don’t sell for $19.
Hey, not my money. If an athlete — or a wannabe — thinks that a compression sleeve helps them, good for them. If they think it makes them look badass, well, even better for them. But, gosh, I sure hope no one things it’s gonna help them hit a baseball or anything.
Colby Rasmus isn’t ready to take outfield reps just yet. According to Rays’ manager Kevin Cash, that’s a red flag, one that could potentially postpone Rasmus’ debut as the club’s designated hitter and outfielder in 2017. Marc Topkin of the Tampa Bay Times reports that Rasmus will need to prove he can play a defensive position before getting cleared for the active roster, something which the veteran outfielder has yet to do this spring.
Rasmus, 30, signed a one-year, $5 million deal with the Rays following his two-year run with the Astros. He batted a meager .206/.286/.355 with 15 home runs and a .641 OPS in 2016 and was shut down in late September with an unspecified hip/groin issue. Entering the 2017 season, he’s expected to work his way back to a full-time role after undergoing surgery to repair his core muscle and left hip labrum last October.
The Rays also finalized their one-year, $1.2 million deal with catcher Derek Norris on Saturday and will need to clear room for him on the 40-man roster. Topkin speculates that the move could send Rasmus to the 60-day disabled list, though the outfielder is not projected to miss more than a couple weeks of the regular season.
The Rangers have reportedly agreed to a six-year, $49.5 million extension for second baseman Rougned Odor, according to Jon Heyman of FanRag Sports and Evan Grant of the Dallas Morning News. The extension comes with a club option for a seventh year, Heyman adds.
It’s close to the six-year, $52.5 million extension Jason Kipnis netted with the Indians in 2014, a sum Odor was rumored to be seeking during contract negotiations over the last two years. Granted, the circumstances are a little different this time around. Both players signed extensions on the cusp of their fourth year in the major leagues, but at 27 years old, Kipnis was coming off of an All-Star campaign and a career-high 4.5 fWAR performance. Odor, meanwhile, saw mixed results in 2016, batting 33 home runs and putting up 2.0 fWAR while struggling to stay consistent at the plate and exhibiting poor defense.
According to MLB.com’s T.R. Sullivan, Odor previously agreed to a $563,180 salary for 2017. Depending on when the extension kicks in, it should cover all three of Odor’s arbitration-eligible seasons and two seasons of potential free agency. The team has yet to confirm the extension.